Home | Welcome to Contract Pharma   
Last Updated Tuesday, September 2 2014
Print

Breaking News

Related Searches: catalent Pharma GMP Phase I
December 2, 2013
Regensburg site to manufacture four solid and semi-solid, high-potent products  Read More »
December 2, 2013
Catalent to provide capsules for ongoing trials and commercial supply  Read More »
Gil Roth
December 2, 2013
AcelRx, Ampio, Biogen Idec, Exelixis, Idenix, Polaris  Read More »
December 2, 2013
Gioia brings 25 years of industry experience  Read More »
December 2, 2013
Installation completed at Taiwan facility  Read More »
December 2, 2013
Advances ISIS-TTR in FAP  Read More »
December 2, 2013
Vellanki and Chow take on CBO and CFO roles  Read More »
December 2, 2013
Sandoz to market authorized generic in the U.S.  Read More »
December 2, 2013
Goldman to establish new partnerships and pursue strategic acquisitions  Read More »
December 2, 2013
Poitiers lab receives GMP certification  Read More »
November 27, 2013
Cho to oversee the Contract Research Services business  Read More »
November 27, 2013
Ploch brings 18 years of experience  Read More »
November 27, 2013
Mylan-Biocon, Cerecor, ARMO BioSciences, GSK, J&J, and more   Read More »
November 26, 2013
Cruz to manage all legal matters and global compliance  Read More »
November 26, 2013
Will combine BioNet's Pertussis Toxin with DBV's Viaskin technology  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On